Oncogene Cancer Research

Given some ALK & NTRK lung cancer targeted therapies are linked to weight gain, patients regularly raise the use of GLP-1 agonists. Important to explore if they affect TKI effectiveness, especially those relying on dietary fat. Thank you International Association for the Study of Lung Cancer for this article. #WorthReading #lungcancer #research

To mark World Health Day, which is focusing on women's health this year, we shed light on the alarming rise of lung cancer among women globally. Did you know that anyone can get lung cancer? The only risk factors are having lungs. By highlighting these statistics, we hope to not only raise awareness about the increasing impact of lung cancer on women, but the need for more early detection and research. Let’s continue to work together to change these stats for all. #WorldHealthDay #cancer #women #research

We are looking forward to taking part in the Lung Cancer Europe AGM and meeting next week in Berlin. By working together across patient organisations we can achieve outcomes for our lung cancer community faster. We are #StrongerTogether. #cancer #lungcancer

Our co-founder Jan Clark’s daughter Amy was diagnosed with stage 4 lung cancer at just 20 years old. Amy was told she would need to go in chemo but a biomarker test revealed an ALK-positive mutation. This meant Amy went on to take a targeted therapy - an oral medication that inhibits her cancer and is much more tolerable. Five years on, Amy is still on that treatment, works full-time and has a full life. Here Jan explains more. Biomarker testing means being put on the right treatment at the right time. Please help us create more awareness of biomarker testing by sharing. 🩵 Thank you to Lung Cancer Europe for the creation of this film.

Happy Mother’s Day to all the incredible mothers and mother figures across the UK. With so many lung cancers disproportionately impacting women, we send love to everyone facing this. May research and science bring each of us the greatest gift: more time. Thinking of those missing their mums, those longing to be mothers, and those facing complicated relationships today. We see you. You are not alone. Happy Mothering Sunday to all. #MothersDay #cancer #lungcancer l

The lung cancer patient advocacy sessions at the European Lung Cancer Congress, including ‘From Screening to Survivorship,’ were standout events. Featured here are key contributors (from left): David Baldwin, Merel Hennink Longkanker Nederland, Anne-Marie Baird, our President, and Jill Feldman. Thank you to all the speakers for their valuable insights and everyone involved in organising the sessions. #LungCancerAwareness #PatientAdvocacy #LCSM #ELCC25

Great initiative, please support by participating on the links below. Every patient should have access to clinical trials, unfortunately lack of particpants can cause the trial to fail.

Today's clinical trials are tomorrow's standards of care. Yet they are often misunderstood and thought of only as a 'last resort' when you've run through all treatment lines. How can we make it easier to introduce clinical trials in our respective countries across Europe? What's it like to take part? If you're keen to understand any of these questions, be sure to join this Lung Cancer Europe webinar with these excellent speakers. Details and registration links below. 👇

Your voices matter: Great opportunity to inform these new guidelines

Not all lung cancers are the same. Advances in precision medicine have given us specific treatments based on certain genetic changes in a tumor—but only if those changes are identified. Comprehensive genetic profiling helps match patients with the most effective, therapies, improving outcomes and quality of life. Help us raise awareness and be sure to ask about full biomarker testing if you or a loved one is being diagnosed. Knowledge is power. #LungCancer #BiomarkerTesting #PrecisionMedicine